{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:19:38Z","timestamp":1790961578853,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.clim.2015.10.004","type":"journal-article","created":{"date-parts":[[2015,10,24]],"date-time":"2015-10-24T15:00:03Z","timestamp":1445698803000},"page":"43-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Natural killer cells from psoriasis vulgaris patients have reduced levels of cytotoxicity associated degranulation and cytokine production"],"prefix":"10.1016","volume":"177","author":[{"given":"S.E.","family":"Dunphy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.M.","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Tobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.M.","family":"Gardiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2015.10.004_bb0005","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nri1689","article-title":"Getting under the skin: the immunogenetics of psoriasis","volume":"5","author":"Bowcock","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2015.10.004_bb0010","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clim.2013.10.009","article-title":"Up-regulation of microRNA-210 induces immune dysfunction via targeting FOXP3 in CD4(+) T cells of psoriasis vulgaris","volume":"150","author":"Zhao","year":"2014","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2015.10.004_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2567.2005.02256.x","article-title":"Putting the natural killer cell in its place","volume":"117","author":"O'Connor","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.clim.2015.10.004_bb0020","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.gene.2013.06.015","article-title":"Protective effect of the KIR2DS1 gene in atopic dermatitis","volume":"527","author":"Niepieklo-Miniewska","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.clim.2015.10.004_bb0025","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaci.2009.11.020","article-title":"Natural killer cells in atopic and autoimmune diseases of the skin","volume":"125","author":"von Bubnoff","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2015.10.004_bb0030","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/sj.jid.5700527","article-title":"T helper type 2-biased natural killer cell phenotype in patients with pemphigus vulgaris","volume":"127","author":"Takahashi","year":"2007","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.clim.2015.10.004_bb0035","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2249.2008.03638.x","article-title":"Possible role of natural killer cells in pemphigus vulgaris \u2014 preliminary observations","volume":"152","author":"Stern","year":"2008","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2015.10.004_bb0040","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/08916934.2011.606446","article-title":"The role of natural killer cells in autoimmune blistering diseases","volume":"45","author":"Zakka","year":"2012","journal-title":"Autoimmunity"},{"key":"10.1016\/j.clim.2015.10.004_bb0045","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/BF00407735","article-title":"Defective natural-killer- and killer-cell activity associated with increased polymorphonuclear leukocyte adherence in psoriasis","volume":"278","author":"Majewski","year":"1986","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.clim.2015.10.004_bb0050","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-2133.1984.tb04679.x","article-title":"Decreased natural killer cell activity in generalized pustular psoriasis (von Zumbusch type)","volume":"110","author":"Kaminski","year":"1984","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.clim.2015.10.004_bb0055","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1365-2133.2012.10814.x","article-title":"Peripheral natural killer cells exhibit qualitative and quantitative changes in patients with psoriasis and atopic dermatitis","volume":"166","author":"Luci","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.clim.2015.10.004_bb0060","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF00417394","article-title":"Natural killer cell activity in psoriasis vulgaris","volume":"271","author":"Hunyadi","year":"1981","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.clim.2015.10.004_bb0065","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1081\/IMM-100105063","article-title":"Natural killer cell activity, serum immunoglobulins, complement proteins, and zinc levels in patients with psoriasis vulgaris","volume":"30","author":"Ozturk","year":"2001","journal-title":"Immunol. Investig."},{"key":"10.1016\/j.clim.2015.10.004_bb0070","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/09629350310001619753","article-title":"Simultaneous measurement of multiple Th1 and Th2 serum cytokines in psoriasis and correlation with disease severity","volume":"12","author":"Jacob","year":"2003","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.clim.2015.10.004_bb0075","first-page":"40","article-title":"Serum cytokine levels in psoriasis vulgaris","volume":"58","author":"el Barnawi","year":"2001","journal-title":"Br. J. Biomed. Sci."},{"key":"10.1016\/j.clim.2015.10.004_bb0080","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0165-2478(03)00025-7","article-title":"Elevated rate of Thelper1 (T(H)1) lymphocytes and serum IFN-gamma levels in psoriatic patients","volume":"86","author":"Szegedi","year":"2003","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.clim.2015.10.004_bb0085","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1346-8138.2010.01018.x","article-title":"Serum levels of interleukin-8, tumor necrosis factor-alpha and gamma-interferon in Egyptian psoriatic patients and correlation with disease severity","volume":"38","author":"Abdel-Hamid","year":"2011","journal-title":"J. Dermatol."},{"key":"10.1016\/j.clim.2015.10.004_bb0090","first-page":"147","article-title":"Plasma concentrations of IFN-gamma and TNF-alpha in psoriatic patients before and after local treatment with dithranol ointment","volume":"10","author":"Chodorowska","year":"1998","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.clim.2015.10.004_bb0095","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1155\/MI.2005.273","article-title":"Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity","volume":"2005","author":"Arican","year":"2005","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.clim.2015.10.004_bb0100","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/archderm.1991.01680050071006","article-title":"Interleukin 1 alpha, tumor necrosis factor alpha, and interferon gamma in psoriasis","volume":"127","author":"Gomi","year":"1991","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.clim.2015.10.004_bb0105","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/eji.200535503","article-title":"IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis","volume":"36","author":"Wolk","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2015.10.004_bb0110","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00403-011-1159-3","article-title":"Kinetics of circulating Th17 cytokines and adipokines in psoriasis patients","volume":"303","author":"Nakajima","year":"2011","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.clim.2015.10.004_bb0115","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2230.2009.03704.x","article-title":"Serum cytokines and growth factor levels in Japanese patients with psoriasis","volume":"35","author":"Takahashi","year":"2010","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.clim.2015.10.004_bb0120","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1365-4632.2004.02082.x","article-title":"Serum levels of proinflammatory cytokines in psoriasis patients from Saudi Arabia","volume":"44","author":"Abanmi","year":"2005","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.clim.2015.10.004_bb0125","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1365-4632.2008.03677.x","article-title":"Serum levels of the pro-inflammatory cytokine interleukin-12 and the anti-inflammatory cytokine interleukin-10 in patients with psoriasis treated by the Goeckerman regimen","volume":"47","author":"Borska","year":"2008","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.clim.2015.10.004_bb0130","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1468-3083.2008.03064.x","article-title":"Serum and tissue expression of transforming growth factor beta 1 in psoriasis","volume":"23","author":"Zaher","year":"2009","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.clim.2015.10.004_bb0135","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/cyto.2002.1953","article-title":"Association between psoriasis severity and transforming growth factor beta(1) and beta (2) in plasma and scales from psoriatic lesions","volume":"19","author":"Flisiak","year":"2002","journal-title":"Cytokine"},{"key":"10.1016\/j.clim.2015.10.004_bb0140","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/13547500310001599061","article-title":"Plasma transforming growth factor beta1 as a biomarker of psoriasis activity and treatment efficacy","volume":"8","author":"Flisiak","year":"2003","journal-title":"Biomarkers"},{"key":"10.1016\/j.clim.2015.10.004_bb0145","first-page":"2","article-title":"Serum concentrations of transforming growth factor beta 1 in patients with psoriasis vulgaris","volume":"12","author":"Nockowski","year":"2004","journal-title":"Acta Dermatovenerol. Croat."},{"key":"10.1016\/j.clim.2015.10.004_bb0150","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1365-2230.2008.03026.x","article-title":"Serum levels of transforming growth factor-beta1 in patients with mild psoriasis vulgaris and effect of treatment with biological drugs","volume":"34","author":"Kallimanis","year":"2009","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.clim.2015.10.004_bb0155","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s10875-008-9233-0","article-title":"Serum levels of IL-17 and IL-22 are reduced by etanercept, but not by acitretin, in patients with psoriasis: a randomized-controlled trial","volume":"29","author":"Caproni","year":"2009","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2015.10.004_bb0160","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jdermsci.2010.03.018","article-title":"Serum IL-22 correlates with psoriatic severity and serum IL-6 correlates with susceptibility to phototherapy","volume":"58","author":"Lo","year":"2010","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.clim.2015.10.004_bb0165","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1684\/ejd.2011.1335","article-title":"Effect of methotrexate on serum levels of IL-22 in patients with psoriasis","volume":"21","author":"Meephansan","year":"2011","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.clim.2015.10.004_bb0170","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1046\/j.1365-2133.2003.05319.x","article-title":"Circulating natural killer cells in psoriasis","volume":"149","author":"Cameron","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.clim.2015.10.004_bb0175","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2133.2009.09178.x","article-title":"Upregulation of Fas and downregulation of CD94\/NKG2A inhibitory receptors on circulating natural killer cells in patients with new-onset psoriasis","volume":"161","author":"Son","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.clim.2015.10.004_bb0180","doi-asserted-by":"crossref","first-page":"355","DOI":"10.18388\/abp.2009_2468","article-title":"Chemerin and the recruitment of NK cells to diseased skin","volume":"56","author":"Skrzeczynska-Moncznik","year":"2009","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.clim.2015.10.004_bb0185","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/exd.12060","article-title":"Skewed distribution of natural killer cells in psoriasis skin lesions","volume":"22","author":"Batista","year":"2013","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.clim.2015.10.004_bb0190","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1046\/j.1365-2249.2002.01721.x","article-title":"CD3+CD56+ NK T cells are significantly decreased in the peripheral blood of patients with psoriasis","volume":"127","author":"Koreck","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2015.10.004_bb0195","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1056\/NEJM197210122871503","article-title":"Histocompatibility (HL-A) antigens associated with psoriasis","volume":"287","author":"Russell","year":"1972","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2015.10.004_bb0200","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2133.1980.tb05690.x","article-title":"Psoriasis and HLA-Cw6","volume":"102","author":"Tiilikainen","year":"1980","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.clim.2015.10.004_bb0205","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1093\/hmg\/6.8.1349","article-title":"Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan","volume":"6","author":"Nair","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.clim.2015.10.004_bb0210","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/hmg\/6.5.813","article-title":"Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis","volume":"6","author":"Trembath","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.clim.2015.10.004_bb0215","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1046\/j.1523-1747.1998.00213.x","article-title":"Genetics of psoriasis: paternal inheritance and a locus on chromosome 6p","volume":"110","author":"Burden","year":"1998","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.clim.2015.10.004_bb0220","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1086\/503821","article-title":"Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene","volume":"78","author":"Nair","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.clim.2015.10.004_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000038","article-title":"Fine mapping of the psoriasis susceptibility locus PSORS1 supports HLA-C as the susceptibility gene in the Han Chinese population","volume":"4","author":"Fan","year":"2008","journal-title":"PLoS Genet."},{"key":"10.1016\/j.clim.2015.10.004_bb0230","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s00439-005-0048-2","article-title":"Localization of PSORS1 to a haplotype block harboring HLA-C and distinct from corneodesmosin and HCR","volume":"118","author":"Helms","year":"2005","journal-title":"Hum. Genet."},{"key":"10.1016\/j.clim.2015.10.004_bb0235","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.immunol.20.092501.134942","article-title":"KIR: diverse, rapidly evolving receptors of innate and adaptive immunity","volume":"20","author":"Vilches","year":"2002","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2015.10.004_bb0240","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.4049\/jimmunol.169.6.2818","article-title":"Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles","volume":"169","author":"Martin","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2015.10.004_bb0245","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.4049\/jimmunol.173.7.4273","article-title":"Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection\/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis","volume":"173","author":"Nelson","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2015.10.004_bb0250","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.humimm.2004.05.008","article-title":"Gene for the activating natural killer cell receptor, KIR2DS1, is associated with susceptibility to psoriasis vulgaris","volume":"65","author":"Luszczek","year":"2004","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.clim.2015.10.004_bb0255","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.humimm.2006.04.001","article-title":"A role for KIR gene variants other than KIR2DS1 in conferring susceptibility to psoriasis","volume":"67","author":"Ploski","year":"2006","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.clim.2015.10.004_bb0260","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.humimm.2005.04.005","article-title":"Activating killer cell immunoglobulin-like receptor gene KIR2DS1 is associated with psoriatic arthritis","volume":"66","author":"Williams","year":"2005","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.clim.2015.10.004_bb0265","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.0022-202X.2005.23879.x","article-title":"Distinct HLA-C\/KIR genotype profile associates with guttate psoriasis","volume":"125","author":"Holm","year":"2005","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.clim.2015.10.004_bb0270","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1038\/sj.jid.5700415","article-title":"The killer cell immunoglobulin-like receptor genes do not confer susceptibility to psoriasis vulgaris independently in Chinese","volume":"126","author":"Chang","year":"2006","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.clim.2015.10.004_bb0275","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1399-0039.2008.01096.x","article-title":"A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris","volume":"72","author":"Jobim","year":"2008","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.clim.2015.10.004_bb0280","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.trim.2005.03.002","article-title":"KIR genes","volume":"14","author":"Middleton","year":"2005","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.clim.2015.10.004_bb0285","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1744-313X.2010.00906.x","article-title":"Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay","volume":"37","author":"Tajik","year":"2010","journal-title":"Int. J. Immunogenet."},{"key":"10.1016\/j.clim.2015.10.004_bb0290","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1399-0039.1995.tb03127.x","article-title":"Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP)","volume":"46","author":"Bunce","year":"1995","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.clim.2015.10.004_bb0295","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jim.2004.08.008","article-title":"CD107a as a functional marker for the identification of natural killer cell activity","volume":"294","author":"Alter","year":"2004","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.clim.2015.10.004_bb0300","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1084\/jem.178.2.597","article-title":"P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities","volume":"178","author":"Moretta","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2015.10.004_bb0305","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1084\/jem.182.3.875","article-title":"Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells","volume":"182","author":"Moretta","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2015.10.004_bb0310","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1744-313X.2008.00779.x","article-title":"HLA-A, B, Cw, DRB1, DQB1 and DPB1 alleles and haplotypes in the genetically homogenous Irish population","volume":"35","author":"Dunne","year":"2008","journal-title":"Int. J. Immunogenet."},{"key":"10.1016\/j.clim.2015.10.004_bb0315","doi-asserted-by":"crossref","first-page":"7736","DOI":"10.4049\/jimmunol.176.12.7736","article-title":"NK cells and gamma delta+ T cells are phenotypically and functionally defective due to preferential apoptosis in patients with atopic dermatitis","volume":"176","author":"Katsuta","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2015.10.004_bb0320","first-page":"337","article-title":"Decreased natural killer cell activity in atopic eczema","volume":"56","author":"Hall","year":"1985","journal-title":"Immunology"},{"key":"10.1016\/j.clim.2015.10.004_bb0325","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000235196","article-title":"Selective alterations in natural killer cell subsets in patients with atopic dermatitis","volume":"92","author":"Wehrmann","year":"1990","journal-title":"Int. Arch. Allergy Appl. Immunol."},{"key":"10.1016\/j.clim.2015.10.004_bb0330","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.clim.2012.12.004","article-title":"Targeting IL-17 in psoriasis: from cutaneous immunobiology to clinical application","volume":"146","author":"Ariza","year":"2013","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2015.10.004_bb0335","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1084\/jem.20010934","article-title":"Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells","volume":"195","author":"Piccioli","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2015.10.004_bb0340","doi-asserted-by":"crossref","first-page":"6365","DOI":"10.4049\/jimmunol.163.12.6365","article-title":"Targeting of human dendritic cells by autologous NK cells","volume":"163","author":"Wilson","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2015.10.004_bb0345","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1002\/(SICI)1521-4141(199912)29:12<4022::AID-IMMU4022>3.0.CO;2-O","article-title":"Recognition of autologous dendritic cells by human NK cells","volume":"29","author":"Carbone","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2015.10.004_bb0350","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/1521-4141(200106)31:6<1656::AID-IMMU1656>3.0.CO;2-V","article-title":"NK cell-mediated lysis of autologous antigen-presenting cells is triggered by the engagement of the phosphatidylinositol 3-kinase upon ligation of the natural cytotoxicity receptors NKp30 and NKp46","volume":"31","author":"Spaggiari","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2015.10.004_bb0355","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1084\/jem.20011149","article-title":"Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells","volume":"195","author":"Ferlazzo","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2015.10.004_bb0360","doi-asserted-by":"crossref","first-page":"6031","DOI":"10.4049\/jimmunol.1000176","article-title":"The rapid induction of HLA-E is essential for the survival of antigen-activated naive CD4 T cells from attack by NK cells","volume":"185","author":"Takao","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2015.10.004_bb0365","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1182\/blood-2006-10-052720","article-title":"Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM\/ATR-dependent mechanism and become susceptible to autologous NK-cell lysis","volume":"110","author":"Cerboni","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.clim.2015.10.004_bb0370","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-3083.2010.02435.x","article-title":"Interleukin-10 promotes NK cell killing of autologous macrophages by stimulating expression of NKG2D ligands","volume":"72","author":"Schulz","year":"2010","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.clim.2015.10.004_bb0375","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/eji.200535243","article-title":"CD56brightCD16(\u2212) NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation","volume":"36","author":"Ottaviani","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2015.10.004_bb0380","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00403-002-0349-4","article-title":"Natural killer and natural killer-T cells in psoriasis","volume":"294","author":"Cameron","year":"2002","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.clim.2015.10.004_bb0385","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/bjd.12658","article-title":"Increased number and frequency of group 3 innate lymphoid cells in nonlesional psoriatic skin","volume":"170","author":"Dyring-Andersen","year":"2014","journal-title":"Br. J. Dermatol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661615300528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661615300528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T12:01:03Z","timestamp":1692100863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661615300528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":77,"alternative-id":["S1521661615300528"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2015.10.004","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural killer cells from psoriasis vulgaris patients have reduced levels of cytotoxicity associated degranulation and cytokine production","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2015.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}